论文部分内容阅读
目的观察天麻素注射液联合倍他司汀治疗急诊眩晕症的临床疗效。方法选取我院2016年1月~2016年12月收治的符合纳入标准的急诊眩晕症患者86例为本次研究对象,分成对照组和观察组,各43例,所有患者均实施常规治疗,其中对照组在此基础上给予倍他司汀治疗,观察组在对照组基础上联合天麻素注射液治疗。比较对照组和观察组患者临床疗效及不良反应发生情况。结果两组患者治疗结束后,眩晕症判定结果显示,和对照组患者相比观察组治疗总有效率明显偏高(95.3%vs81.4%),差异有统计学意义(P<0.05)。治疗期间,两组患者无严重不良反应病例,两组患者的不良反应发生率差异不大,对比结果显示无统计学差异(9.3%vs14.0%),差异无统计学意义(P>0.05)。结论天麻素联合倍他司汀在急诊眩晕症患者中应用效果良好,治疗有效率高,且不良反应轻微,临床上值得应用。
Objective To observe the clinical efficacy of gastrodin injection combined with Betalistine in the treatment of emergency vertigo. Methods A total of 86 patients with acute vertigo who met the inclusion criteria from January 2016 to December 2016 in our hospital were selected as control group and observation group, 43 cases in each group. All patients received routine treatment, of which, The control group was treated with betahistine on this basis. The observation group was treated with gastrodin injection on the basis of the control group. The clinical efficacy and adverse reactions of the control group and observation group were compared. Results After the two groups of patients were treated, the results of vertigo judgment showed that the total effective rate of the observation group was significantly higher than that of the control group (95.3% vs81.4%, P <0.05). There was no significant difference between the two groups (P> 0.05). There was no significant difference between the two groups (9.3% vs14.0%) (P> 0.05) . Conclusion Gastrodin combined with Betatine in patients with acute vertigo has a good effect, high treatment efficiency, and mild adverse reactions, which is worthy of clinical application.